BridgeBio Oncology Therapeutics, Inc.
Institutional holders · 13F as of Dec 31, 2025
| Holder | Value | % of shares |
|---|---|---|
| Citadel Advisors LLC | $31.68M | 3.16% |
| Enavate Sciences GP, LLC | $32.89M | 3.28% |
| EcoR1 Capital, LLC | $35.35M | 3.52% |
| Wellington Management Group LLP | $36.40M | 3.63% |
| Omega Fund Management, LLC | $41.19M | 4.10% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $43.72M | 6.09% |
| Cormorant Asset Management, LP | $223.84M | 22.30% |